top of page

Lund based Asgard Therapeutics aims to turn tumor cells into a type of dendritic cell inside the body so that the immune system can learn the tumor's signature and fight it systemically

  • 3 days ago
  • 1 min read

Co-Founder and CEO Cristiana Pires describes this unique approach, which is in late stage pre-IND work and recently was presented at AACR and ASGCT. The company already has an impressive roster of investors backing it.






Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page